Janet Dorling
Corporate Officer/Principal en GILEAD SCIENCES, INC. .
Cargos activos de Janet Dorling
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/05/2020 | - |
Gilead Sciences Belgium BV
Gilead Sciences Belgium BV Medical DistributorsDistribution Services Gilead Sciences Belgium BV is a Belgian company that was founded in 2006. The private company is based in Machelen, Belgium. The company provides a portal for healthcare professionals under the name Gilead Sciences. | Director/Miembro de la Junta | 01/02/2023 | - |
Historial de carrera de Janet Dorling
Antiguos cargos conocidos de Janet Dorling.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CYMABAY THERAPEUTICS, INC. | Director/Miembro de la Junta | 05/04/2021 | 22/03/2024 |
CYMABAY THERAPEUTICS, INC. | Corporate Officer/Principal | 05/08/2019 | 01/12/2019 |
ACHAOGEN | Corporate Officer/Principal | 27/02/2017 | 30/06/2019 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2015 | 01/01/2017 |
Formación de Janet Dorling.
Duke University | Graduate Degree |
University of California, Berkeley | Masters Business Admin |
Haas School of Business | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 7 |
Suiza | 2 |
Bélgica | 2 |
Operativa
Corporate Officer/Principal | 4 |
Masters Business Admin | 2 |
Director/Board Member | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 4 |
Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
ROCHE HOLDING AG | Health Technology |
Empresas privadas | 3 |
---|---|
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Gilead Sciences Belgium BV
Gilead Sciences Belgium BV Medical DistributorsDistribution Services Gilead Sciences Belgium BV is a Belgian company that was founded in 2006. The private company is based in Machelen, Belgium. The company provides a portal for healthcare professionals under the name Gilead Sciences. | Distribution Services |
- Bolsa de valores
- Insiders
- Janet Dorling
- Experiencia